Results 11 to 20 of about 18,158,432 (307)
Gefässchirurgie, 2020 Structural model of SARS-CoV-2 including the X rays structure of the spikes (PDB ID 6VSB). The model is composed of cryoEM density from SARS-CoV-1 for the core and SARS-CoV-2 spikes pdbs.
Steinbauer, M., Böckler, D.
openaire +4 more sources
SARS‐CoV‐2 and myasthenia [PDF]
Journal of Medical Virology, 2021 The COVID-19 pandemic due to infection with SARS-CoV-2 not only affects political, economic, social, and cultural life, but also has a significant impact on medicine. This article is protected by copyright. All rights reserved.
Finsterer, Josef +3 more
openaire +2 more sources
Epidemiology of SARS-CoV-2 [PDF]
Infection, 2020 Abstract Purpose SARS-CoV-2 is a recently emerged ß-coronavirus. Here we present the current knowledge on its epidemiologic features. Methods Non-systematic review.
Salzberger, Bernd +7 more
openaire +3 more sources
Cell Host & Microbe, 2021 A previously immune-naive world population is experiencing natural infection with SARS-CoV-2. Severe COVID-19 predominantly impacts adults, yet multisystem inflammatory disorder primarily impacts children. Herein, we discuss known clinical and biological features of SARS-CoV-2 in children and reflect on currently identified immune features and discuss ...
Bogunovic, Dusan, Merad, Miriam
openaire +2 more sources
There is no “origin” to SARS-CoV-2
Environmental Research, 2022 Since the beginning of the COVID-19 pandemic in 2020 caused by SARS-CoV-2, the question of the origin of this virus has been a highly debated issue. Debates have been, and are still, very disputed and often violent between the two main hypotheses: a natural origin through the "spillover" model or a laboratory-leak origin.
Frutos, Roger +3 more
openaire +5 more sources
Anti-SARS-CoV-2 S-RBD IgG antibody and anti-SARS-CoV-2 NAb levels. [PDF]
, 2023 Anti-SARS-CoV-2 S-RBD IgG antibody and anti-SARS-CoV-2 NAb levels.
Lugyanti Sukrisman (4808703) +11 more
core +1 more source
Immunological Medicine, 2022 SARS-CoV-2 virus has become a global health problem that has caused millions of deaths worldwide. The infection can present with multiple clinical features ranging from asymptomatic or mildly symptomatic patients to patients with severe or critical illness that can even lead to death.
Dennis Jiménez, Marbel Torres Arias
openaire +3 more sources
Amantadine Inhibits SARS-CoV-2 In Vitro [PDF]
, 2021 Since the SARS-CoV-2 pandemic started in late 2019, the search for protective vaccines and for drug treatments has become mandatory to fight the global health emergency. Travel restrictions,social distancing, and face masks are suitable counter measures,
Danysz, Wojciech +11 more
core +1 more source
SARS-CoV-2 Aerosol and Intranasal Exposure Models in Ferrets [PDF]
, 2023 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the worldwide COVID-19 pandemic. Animal models are extremely helpful for testing vaccines and therapeutics and for dissecting the viral and host factors that ...
John M. Dye +15 more
core +1 more source
Effectiveness of prevention of SARS-CoV-2 transmission among unvaccinated Italian healthcare workers [PDF]
, 2022 BACKGROUND: We aimed to investigate the association between personal protective equipment (PPE) use and SARS-CoV-2 infection among healthcare workers (HCWs).
Coggiola, Maurizio +10 more
core +1 more source